assospharma.com 的前十大競爭對手

alfresa-pharma.co.jp

アルフレッサファーマは、医薬品、診断薬、医療機器などを開発・製造・販売する医療メーカーです。医療を総合的にバックアップし、世界中の人々の健康に貢献していきます。

e-cspc.com

CSPC

abbott.in

In line with the Government’s move to encourage digital economy, Abbott India Limited / Abbott Healthcare Private Limited / St. Jude Medical India Private Limited are pleased to provide following additional electronic modes of payment to its customers

farmareyon.com

Natura Siberica Lab Biome Hydration Face Serum, 30 ml

dermoeczanem.com

Eğer lekeye eğilimli bir cildiniz varsa, lekeli ciltler için olan bakım ürünlerini tercih etmelisiniz. Bu ürünlere Dermoeczanem'den ulaşabilirsiniz.

tre-belgium.com

TRE - tension release exercises. Alle info voor TRE in België kan je hier op deze website vinden. We vertegenwoordigen TRE internationaal.

brookes.com.pk

Re-Uptol (Escitalopram) is an orally administered selective serotonin reuptake inhibitor (SSRI). The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT). Re-Uptol (Escitalopram) is a highly selective serotonin reuptake inhibitor (SSRI) with minimal effects on norepinephrine and dopamine neuronal reuptake. Re-Uptol (Escitalopram) has no or very low affinity for serotonergic (5-HT1-7) or other receptors including alpha- and beta-adrenergic, dopamine (D1-5), histamine (H1-3), muscarinic (M1-5), and benzodiazepine receptors. Re-Uptol (Escitalopram) also does not bind to, or has low affinity for, various ion channels including Na+, K+, Cl-, and Ca++ channels.